CEDARS/ASPENS DebatesPublication Exclusive

How do surgeons approach enhancements in refractive surgery patients?

CEDARS Debates is a monthly feature in Ocular Surgery News. CEDARS — Cornea, External Disease, and Refractive Surgery Society — is a group of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

As laser refractive surgery enters its third decade of widespread use in the U.S., an increasing number of patients are now returning for enhancements. LASIK patients, in particular, present the dilemma of how to approach the enhancement.

Ken Beckman

Kenneth A. Beckman

While some surgeons prefer to lift the previous flap or to cut a new flap, others prefer surface treatment to avoid the complications of creating or lifting a flap. There are numerous advantages and pitfalls to both techniques. This month, Thomas S. Boland, MD, and Damien F. Goldberg, MD, discuss the pros and cons of lifting the old flap and using surface treatment. We hope you enjoy the discussion.

Kenneth A. Beckman, MD, FACS

OSN CEDARS Debates Editor

Click here to read the full publication exclusive.

CEDARS Debates is a monthly feature in Ocular Surgery News. CEDARS — Cornea, External Disease, and Refractive Surgery Society — is a group of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

As laser refractive surgery enters its third decade of widespread use in the U.S., an increasing number of patients are now returning for enhancements. LASIK patients, in particular, present the dilemma of how to approach the enhancement.

Ken Beckman

Kenneth A. Beckman

While some surgeons prefer to lift the previous flap or to cut a new flap, others prefer surface treatment to avoid the complications of creating or lifting a flap. There are numerous advantages and pitfalls to both techniques. This month, Thomas S. Boland, MD, and Damien F. Goldberg, MD, discuss the pros and cons of lifting the old flap and using surface treatment. We hope you enjoy the discussion.

Kenneth A. Beckman, MD, FACS

OSN CEDARS Debates Editor

Click here to read the full publication exclusive.